Cidara Therapeutics Payables and Accrued Expenses (Quarterly) Trends

Cidara Therapeutics, Inc. (CDTX)

221.38 0.00 (0.00%) USD | NASDAQ | Jan 22, 16:00

View Payables and Accrued Expenses (Quarterly) for CDTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Payables and Accrued Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Payables and Accrued Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Payables and Accrued Expenses (Quarterly) Benchmarks

Start Trial

Merck & Co., Inc.	Upgrade
Mersana Therapeutics, Inc. (DELISTED)	Upgrade
Bristol Myers Squibb Co.	Upgrade
Johnson & Johnson	Upgrade
Pfizer Inc.	Upgrade